Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone

• Lidewij T. Warris ,

  * E-mail: l.warris@erasmusmc.nl

  Affiliations Department of Pediatric Oncology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands, Department of Pediatric Endocrinology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

  ⨯
• Erica L. T. van den Akker,

  Affiliation Department of Pediatric Endocrinology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands

  ⨯
• Marc B. Bierings,

  Affiliations Department of Pediatric Hematology and Oncology, University Medical Center Utrecht – Wilhelmina Children’s Hospital, Utrecht, The Netherlands, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

  ⨯
• Cor van den Bos,

  Affiliation Department of Pediatric Oncology, Academic Medical Center – Emma Children’s Hospital, Amsterdam, The Netherlands

  ⨯
• Christian M. Zwaan,

  Affiliation Department of Pediatric Oncology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands

  ⨯
• Sebastiaan D. T. Sassen,

  Affiliation Department of Pediatric Oncology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands

  ⨯
• Wim J. E. Tissing,

  Affiliation Department of Pediatric Hematology and Oncology, University of Groningen Medical Center, Groningen, The Netherlands

  ⨯
• Margreet A. Veening,

  Affiliation Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, The Netherlands

  ⨯
• Rob Pieters,

  Affiliation Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

  ⨯
• Marry M. van den Heuvel-Eibrink

  Affiliations Department of Pediatric Oncology, Erasmus MC- Sophia Children’s Hospital, Rotterdam, The Netherlands, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

  ⨯